Dimensional Fund Advisors
ARMP icon

Dimensional Fund Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

Dimensional Fund Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,472
Closed -$34.4K – 3416
2023
Q3 		$34.4K Hold
11,472
– – ﹤0.01% 3409
2023
Q2 		$13.1K Hold
11,472
– – ﹤0.01% 3463
2023
Q1 		$19.2K Hold
11,472
– – ﹤0.01% 3438
2022
Q4 		$14 Sell
11,472
-1,600
-12% -$4.17K ﹤0.01% 3473
2022
Q3 		$56K Hold
13,072
– – ﹤0.01% 3389
2022
Q2 		$51K Hold
13,072
– – ﹤0.01% 3384
2022
Q1 		$64K Hold
13,072
– – ﹤0.01% 3438
2021
Q4 		$72K Buy
+13,072
New +$54.6K ﹤0.01% 3461

Other funds holding ARMP

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors's ARMP Position: Q4 2023 in Review

Dimensional Fund Advisors sold out of Armata Pharmaceuticals (ARMP) in Q4 2023, closing a stake of 11,472 shares — an estimated $34.4K sold.

Dimensional Fund Advisors first reported a position in ARMP in Q4 2021 and held it in 8 quarters. The position peaked at $72K in Q4 2021. 25 funds tracked by Wall St. Rank hold ARMP as of Q4 2023.

  • Dimensional Fund Advisors reported no remaining Armata Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 11,472 Armata Pharmaceuticals shares in Q4 2023, an estimated $34.4K.
  • Dimensional Fund Advisors first reported a position in Armata Pharmaceuticals in Q4 2021 and held it in 8 quarters.
  • Dimensional Fund Advisors's Armata Pharmaceuticals position peaked at $72K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2023.

Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.